Javascript is disabled in your browser

Startbase requires Javascript in order to display content.
Please check your browser settings and enable Javascript-Support for this website.

Biotech

News NRW.BANK Invests in Biotech Startup Phagestack The biotech startup from Pulheim combines machine learning and bacteriophages in the fight against antibiotic resistance. With this funding, it has now opened its own laboratory in Cologne.

Marc Nemitz 09.09.2026

News HeartBeat.bio and Cubase Bio Receive One Million Euros for 3D Analysis of Heart Diseases HeartBeat.bio and Cubase Bio are launching the FACTS-3D research project. With one million euros in Eurostars funding, they aim to study human heart organoids in three dimensions down to the level of gene expression.

Marc Nemitz 09.09.2026

News FERAGEN Receives a Six-Figure Investment from Raiffeisen Salzburg More than 40,000 dogs are already registered on myFERAGEN. FERAGEN is now receiving fresh capital from Raiffeisen Salzburg and plans to further expand its AI-powered genetic analyses.

Marc Nemitz 27.08.2026

News Revier Therapeutics Launches with 6 Million Euros in Seed Funding Revier Therapeutics is launching with seed funding and aims to develop novel therapies for cardiometabolic diseases. KHAN-II, HTGF, and VORNvc are among the investors.

Marc Nemitz 26.08.2026

News ÄIO and TFTAK Receive 1.94 Million Euros 97 percent less land, 90 percent less water. ÄIO aims to make microbial oils an industrially competitive alternative. Funding of 1.94 million euros is now available for this project.

Marc Nemitz 25.08.2026

News Exobiosphere Receives One Million Euros in Government Funding for Space Biotech Platform One million euros and no additional company shares. Exobiosphere is receiving the maximum JEI grant available in Luxembourg and plans to use the funds to scale up its space biotech platform internationally.

Marc Nemitz 12.08.2026

News Lilly is acquiring AtaiBeckley for up to $3.8 billion and is focusing on new treatments for treatment-resistant depression Lilly is acquiring AtaiBeckley and significantly expanding its neuroscience pipeline. The focus is on a novel therapy for treatment-resistant depression.

Marc Nemitz 20.07.2026

News 5 million euros for Graph Therapeutics Using AI, patient cells, and multi-omics data, Graph Therapeutics aims to unravel the causes of complex immune disorders.

Marc Nemitz 02.07.2026

News Epitome Therapeutics Launches with 4 Million Euros The EMBL spin-off is developing CADENCE, a platform for the precise control of gene expression, and is launching with €4 million in funding.

Marc Nemitz 30.06.2026

News Isomorphic Labs raises 2.1 billion US dollars in Series B funding 2.1 billion dollars for AI drug development. Isomorphic Labs is scaling its AI drug design platform and wants to fundamentally accelerate drug research.

Marc Nemitz 13.05.2026

1
2
3
4
5
6